Literature DB >> 8888321

Effects of a 2.5-mg silver acetate lozenge on initial and long-term smoking cessation.

N Hymowitz1, H Eckholdt.   

Abstract

BACKGROUND: Silver acetate over-the-counter products, such as gum, lozenge, and spray, produce an aversive metallic taste when combined with cigarette smoke. Hence, they hold promise of serving as an effective smoking deterrent, one that may be used on a self-help basis. PROCEDURE: Five hundred adult smokers, male and female, were assigned randomly to one of two experimental conditions, 2.5-mg silver acetate lozenge and placebo lozenge. A double-blind study of the effects of a 2.5-mg silver acetate lozenge on initial (3 weeks) and long-term (12 months) smoking cessation was carried out.
RESULTS: About 90% of the subjects (n = 500) reported using the lozenge (silver acetate or placebo) for smoking cessation, and they used about five lozenges per day. Over 70% of the quitters (n = 70) reported using the lozenge on an as-needed basis for relapse prevention. The overall objectively verified quit rates for subjects assigned to the silver acetate and placebo conditions at Visit 3 (3 weeks) were 17% (n = 42) and 11% (n = 28), respectively, a difference which approached statistical significance (P = 0.071). When the analysis was restricted to subjects who used the product, a statistically significant difference (P < 0.05) in initial smoking cessation emerged (26%, n = 37 vs 16%, n = 23) for subjects assigned to the silver acetate and placebo conditions. At 12 months follow-up, 26% (n = 11) of initial quitters in the silver acetate condition and 32% (n = 9) of the quitters in the placebo condition were abstinent. This difference was not statistically significant.
CONCLUSIONS: The study demonstrated modest efficacy for the effect of the 2.5-mg silver acetate lozenge on initial smoking cessation for the subset of subjects who used the product as recommended. We failed to demonstrate efficacy of the lozenge for long-term relapse prevention. Additional research on the efficacy of the 2.5-mg silver acetate lozenge and long-term abstinence in general appears warranted.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8888321     DOI: 10.1006/pmed.1996.0087

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  4 in total

Review 1.  A review of tobacco use treatments in U.S. ethnic minority populations.

Authors:  Lisa Sanderson Cox; Kolawole Okuyemi; Won S Choi; Jasjit S Ahluwalia
Journal:  Am J Health Promot       Date:  2011 May-Jun

Review 2.  Current approaches to the management of smoking cessation.

Authors:  Gay Sutherland
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Nanogold plasmon resonance-based glucose sensing. 2. Wavelength-ratiometric resonance light scattering.

Authors:  Kadir Aslan; Joseph R Lakowicz; Chris D Geddes
Journal:  Anal Chem       Date:  2005-04-01       Impact factor: 6.986

Review 4.  Silver acetate for smoking cessation.

Authors:  Tim Lancaster; Lindsay F Stead
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.